Dr. Sergio Giralt (left), Chief of Memorial Sloan Kettering's Adult Bone Marrow Transplant Service and Melvin Berlin Family Chair in Multiple Myeloma, and Dr. Andre Goy, Chairman and Executive Director of the John Theurer Cancer Center, explain how this joint venture will provide higher-quality care to New Jersey residents. One patient who's already benefited is Karen Koehler, pictured on the screen behind the doctors. She was able to receive most of her care at Hackensack and participate in a clinical trial at MSK.
New Jersey Senator Bob Menendez describes how the partnership between Memorial Sloan Kettering and Hackensack Meridian Health will raise the standard for cancer care in the state.
From left: Mr. Lloyd, Dr. Thompson, and Mr. Garrett sign a declaration to officially commence the partnership.
Today, Memorial Sloan Kettering took a bold step toward bringing our unrivaled cancer care to as many people as possible. During a press conference at the future site of the Seton Hall–Hackensack Meridian School of Medicine, leaders from MSK announced a partnership with Hackensack Meridian Health, one of New Jersey’s largest and most prestigious healthcare providers.
The partnership will closely align the two organizations, which will develop joint standards of care through the oversight of a governing board composed of members of both institutions. These guidelines will apply to all partnership sites in New Jersey, which includes MSK’s locations in Basking Ridge, Monmouth County, and Bergen County (opening in 2018) as well as Hackensack’s John Theurer Cancer Center.
The partnership also aims to bring both MSK’s and Hackensack Meridian’s portfolios of hundreds of clinical trials to more patients, increasing the ability to find new treatments for cancer, faster.